Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis

Published:2022-06-20 Issue:6 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Adams Anne¹,Scheckel Benjamin²,Habsaoui Anissa³,Haque Madhuri³,Kuhr Kathrin¹,Monsef Ina³,Bohlius Julia⁴,Skoetz Nicole⁵

Affiliation:

1. Institute of Medical Statistics and Computational Biology; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

2. Institute of Health Economics and Clinical Epidemiology; University of Cologne, Faculty of Medicine and University Hospital Cologne; Cologne Germany

3. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

4. Institute of Social and Preventive Medicine; University of Bern; Bern Switzerland

5. Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference311 articles.

1. Aapro M Barnadas A Leonard RC Marangolo M Untch M Effects of epoetin beta treatment in patients with metastatic breast cancer receiving chemotherapy. Results of the BRAVE trial Breast Cancer Research and Treatment 2006 Abstract 6095

2. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) Study;Aapro;Journal of Clinical Oncology,2008

3. Leonard RC Aapro M Chan S Dirix LY Mayordomo J Reichert D Once weekly epoetin beta in patients with metastatic breast cancer receiving anthracycline- or taxane-based chemotherapy Annals of Oncology 2004 iii.50 (Abstract 188p)

4. Abels R Erythropoietin for anemia in cancer patients European Journal of Cancer 1993 2 8

5. Abels R Recombinant human erythropoietin in the treatment of the anaemia of cancer Acta Haematologica 1992 4 11

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postoperative transfusion hemoglobin threshold and functional recovery after high‐risk oncologic surgery: A randomized controlled pilot study;Transfusion;2023-04-27

2. How does intravenous or oral iron compare with no treatment for people with cancer and anemia?;Cochrane Clinical Answers;2022-09-06